Stéphane Bach

22PUBLICATIONS
81CO-AUTHORS
Proteins and peptidesMolecular targetsBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsNatural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 27, 2026
An Experimentally Validated Structure-Based Virtual Screening Approach to Identify Nucleotide-Binding Protein Inhibitors as a New Source of Kinase Inhibitors.

|Nov 28, 2025
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.

Claire Delehouzé, Melodie Mallais, Arnaud Comte

|Oct 29, 2025
Research towards selective inhibition of the CLK3 kinase.

Vinay Kumar Singh, Frédéric Justaud, Dabbugoddu Brahmaiah

|Jun 27, 2025
New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives.

José Rivaldo De Lima, Alexandre José Da Silva Góes, Elizabeth Fernanda De Oliveira Borba

|Jun 23, 2025
Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1,2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy.

Lhana Tisseur, Cédric Logé, Sandrine Cojean

|Dec 17, 2024
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition.

Lhana Tisseur, Sandrine Cojean, Khadidiatou Gassama

Pageof 4

Frequent Collaborators

9 joint publications

Blandine Baratte

4 joint publications

Cédric Logé

4 joint publications

Pascal Marchand

3 joint publications

Marc-Antoine Bazin